Experiences of a Poison Center with Metformin-Associated Lactic Acidosis

Abstract

Metformin is widely used in the treatment of type 2 diabetes, though it is recognized to be associated with the risk of lactic acidosis. A case of pronounced lactic acidosis with cardiac arrest (pH 6.60, lactate 17.5 mmol/l, base excess - 30, standard bicarbonate 2.5 mmol/l, core body temperature 27.8 °C) is presented in a 61-year-old woman under metformin therapy. The key laboratory abnormalities observed during the intensive care treatment including repeated hemodialysis are described. The patient showed a complete recovery with residually reduced mental capabilities. Furthermore, an explorative data analysis of our poison center database from 1995 until 2003 concerning metformin was performed. In 109 inquiries for metformin a lactic acidosis (mean pH 6.87 ± 0.11, mean lactate 20.9 ± 8.1 mmol/l) was present in 14 cases (9 female, 5 male, average age 57.7 years) with 8 patients under regular metformin therapy and 6 patients who ingested large amounts of metformin to attempt suicide. 4 patients did not survive the severe metabolic disturbance. The present report demonstrates that metformin-associated lactic acidosis is a rare but critical complication of metformin therapy of type 2 diabetes as well as in acute suicidal ingestion of metformin. Early diagnosis and rapid correction of the metabolic acidosis using hemodialysis provides the possibility of a positive outcome even in severe cases. If metformin-associated lactic acidosis is suspected we recommend early involvement of a poison center.

Metformin - lactic acidosis - hemodialysis - poison center

References

• 1 Ahmad S, Beckett M. Recovery from pH 6.38: lactic acidosis complicated by hypothermia.  Emerg Med J. 2002;  19 169-171
• 2 Bailey C J, Turner R C. Metformin.  New Engl J Med. 1996;  334 574-579
• 3 Barrueto F, Meggs W J, Barchman M J. Clearance of metformin by hemofiltration in overdose.  J Toxicol Clin Toxicol. 2002;  40 177-180
• 4 Ben M H, Thabet H, Zaghdoudi I, Amamou M. Metformin-associated acute pancreatitis.  Vet Hum Toxicol. 2002;  44 47-48
• 5 Berner B, Hummel K M, Strutz F, Ritzel U, Ramadori G, Hagenloch S, Kleine P, Muller G A. Metformin-associated lactic acidosis with acute renal failure in type 2 diabetes mellitus.  Med Klin. 2002;  97 99-103
• 6 Campbell I W. Metformin and glibenclamide: comparative risks.  Br Med J. 1984;  289 289
• 7 Chang C T, Chen Y C, Fang J T, Huang C C. Metformin associated lactic acidosis: case report and literature review.  J Nephrol. 2002 a;  15 398-402
• 8 Chang C T, Chen Y C, Fang J T, Huang C C. High anion gap metabolic acidosis in suicide: don't forget metformin intoxication - two patients' experiences.  Ren Fail. 2002 b;  24 671-675
• 9 Gan S C, Barr J, Arieff A I, Pearl R G. Biguanide-associated lactic acidosis: case report and review of the literature.  Arch Intern Med. 1992;  152 2333-2336
• 10 Holstein A, Nahrwold D, Hinze S, Egberts E. Contra-indications to metformin therapy are largely disregarded.  Diabet Med. 1999;  16 692-696
• 21 Kruse J A. Metformin-associated lactic acidosis.  J Emerg Med. 2001;  20 267-272
• 11 Lalau J D, Race J M. Lactic acidosis in metformin therapy: searching for a link with metformin in reports of “metformin-associated lactic acidosis”.  Diab Obes Metab. 2001;  3 195-201
• 12 Luft D, Deichsel G, Schmulling R M, Stein N, Eggstein M. Definition of clinically relevant lactic acidosis in patients with internal diseases.  Am J Clin Pathol. 1983;  80 484-489
• 13 Spiller H A, Quadrani D A. Five year retrospective review of toxic effects from metformin exposure.  J Toxicol Clin Toxicol. 2003;  41 383-564
• 14 Stang M, Wysowski D K, Butler-Jones D. Incidence of lactic acidosis in metformin users.  Diabetes Care. 1999;  22 925-927
• 15 UKPDS Group . Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes.  Lancet. 1998;  352 854-865
• 16 von Mach M A, Weilemann L S. Zunehmende Bedeutung von Antidepressiva bei suizidalen und parasuizidalen Intoxikationen.  Dtsch Med Wochenschr. 2002;  127 2053-2056
• 17 von Mach M A, Brinkmann C, Hansen T, Weilemann L S, Beyer J. Differences in pharmacokinetics and pharmacodynamics of insulin lispro and aspart in healthy volunteers.  Exp Clin Endocrinol Diabetes. 2002;  110 416-419
• 18 von Mach M A, Weilemann L S. Aktuelle Diagnostik von Intoxikationen.  Dtsch Med Wochenschr. 2003 a;  128 1121-1123
• 19 von Mach M A, Weilemann L S. Aktuelle Therapie von Intoxikationen.  Dtsch Med Wochenschr. 2003 b;  128 1779-1781
• 20 von Mach M A, Lauterbach M, Kaes J, Hengstler J G, Weilemann L S. Suizidale und parasuizidale Intoxikationen mit Paracetamol: Eine Analyse von 1995 bis 2002.  Dtsch Med Wochenschr. 2003;  128 15-19